| 1. |
中华医学会风湿病学分会. 系统性红斑狼疮诊断及治疗[J]. 中华风湿病学杂志, 2010, 14(5): 342-346. DOI: 10.3760/cma.j.issn.1007-7480.2010.05.016.Rheumatology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of systemic lupus erythematosus Chinese Medical Association Rheumatology Branch[J]. Chin J Rheumatol, 2010, 14(5): 342-346. DOI: 10.3760/cma.j.issn.1007-7480.2010.05.016.
|
| 2. |
Preble JM, Silpa-archa S, Foster CS. Ocular involvement in systemic lupus erythematosus[J]. Curr Opin Ophthalmol, 2015, 26(6): 540-545. DOI: 10.1097/ICU.0000000000000209.
|
| 3. |
Miguel AI, Henriques F, Azevedo L, et al. Systematic review of Purtscher’s and Purtscher-like retinopathies[J]. Eye (Lond), 2013, 27(1): 1-13. DOI: 10.1038/eye.2012.222.
|
| 4. |
周慧颖, 叶俊杰, 王淑然. 系统性红斑狼疮眼底病变的特征[J]. 中华眼视光学与视觉科学杂志, 2015, 17(5): 270-274. DOI: 10.3760/cma.j.issn.1674-845X.2015.05.004.Zhou HY, Ye JJ, Wang SR. Observation of the ocular fundus manifestations of systemic lupus erythematosus[J]. Chin J Optom Ophthalmol Vis Sci, 2015, 17(5): 270-274. DOI: 10.3760/cma.j.issn.1674-845X.2015.05.004.
|
| 5. |
Hall S, Buettner H, Luthra HS. Occlusive vascular disease in systemic lupus erythematosus[J]. J Rheumatol, 1985, 11(6): 846-850.
|
| 6. |
Conigliaro P, Cesareo M, Chimenti MS, et al. Take a look at the eyes in systemic lupus erythematosus: a novel point of view[J]. Autoimmun Rev, 2019, 18(3): 247-254. DOI: 10.1016/j.autrev.2018.09.011.
|
| 7. |
Glueck CJ, Hutchins RK, Jurantee J, et al. Thrombophilia and retinal vascular occlusion[J]. Clinical Ophthalmology, 2012, 6: 1377-1384. DOI: 10.2147/OPTH.S34627.
|
| 8. |
Zdrojewski Z. Systemic lupus erythematosus and antiphospholipid syndrome-diagnostic and therapeutic problems[J]. Wiad Lek, 2018, 71(1 pt1): 40-46.
|
| 9. |
Akhter E, Shums Z, Norman GL, et al. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus[J]. J Rheumatol, 2013, 40(3): 282-286. DOI: 10.3899/jrheum.120084.
|
| 10. |
Wu C, Dai R, Dong F, et al. Purtscher-like retinopathy in systemic lupus erythematosus[J]. Am J Ophthalmol, 2014, 158(6): 1335-1341. DOI: 10.1016/j.ajo.2014.09.001.
|
| 11. |
Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview[J]. Clin Exp Med, 2018, 18(2): 135-149. DOI: 10.1007/s10238-017-0479-9.
|
| 12. |
Lee DH, Hwang CK, Cukras CA , et al. Two cases of severe Purtscher-like retinopathy demonstrating recurrence and progression to neovascularization and vitreous hemorrhage[J/OL]. Am J Ophthalmol Case Rep, 2020, 18: 100664[2020-03-12]. https://pubmed.ncbi.nlm.nih.gov/32211564/. DOI: 10.1016/j.ajoc.2020.100664.
|
| 13. |
Murray E, Perry M. Off-label use of rituximab in systemic lupus erythematosus: a systematic review[J]. Clin Rheumatol, 2010, 29(7): 707-716. DOI: 10.1007/s10067-010-1387-5.
|
| 14. |
In Yun Y, Kim JH, Lim SH, et al. Case of catastrophic antiphospholipid syndrome presenting as neuroretinitis and vaso-occlusive retinopathy[J]. BMC Ophthalmol, 2020, 20(1): 482. DOI: 10.1186/s12886-020-01755-9.
|
